About TBD Pharmatech

Pharmaceutical API CDMO

Established in 2006, TBD Pharmatech (formerly TBD-Biodiscovery) is a Contract Development and Manufacturing Organization (CDMO) specializing in small-molecule Active Pharmaceutical Ingredients (APIs) and fine chemicals. Our comprehensive services encompass

  • Full-range small-molecule API development and tech transfer
  • Clinical and commercial batch manufacturing
  • Custom synthesis, analytical services, and regulatory support

Operating from two GMP-certified facilities in Tartu, Estonia (the Tiigi site and the newly constructed Välja site) we are committed to delivering tailored solutions to pharmaceutical and biotech companies worldwide.

Our international team ensures compliance with global regulatory standards, fostering enduring partnerships built on quality and client satisfaction.

Get to Know Our team

Andrus Tasa

Andrus Tasa, PhD

Chairman of the Management Board

Andi Kipper

Andi Kipper, PhD

Head of Research and Development Department

Ain Uustare, PhD

Ain Uustare, PhD

Qualified Person, Head of Quality Assurance Department

Tõnis Tasa, PhD

Head of Business Development

Anneli Lainela

Anneli Lainela

Business Development Manager

Sander Kotkas

Head of Manufacturing Department

Facilities

TBD Pharmatech operates two CDMO facilities in Tartu, Estonia.

Tiigi Site: Our original GMP-certified facility, operational since 2008, equipped with advanced laboratories and production units for small-molecule API development and manufacturing.

Välja Site: Our newly constructed, newly GMP-certified facility expands our pilot and commercial manufacturing capacity, strengthening EU-based supply security and enabling reliable niche-to-mid-volume API production.

Certifications

ISO 9001

International quality management standard ensuring structured processes, continuous improvement, and operational consistency across our organization.

ISO certified since 2018.

Good Manufacturing Practice (GMP)

EU regulatory framework governing the compliant manufacture and quality control of pharmaceutical APIs.

Tiigi site GMP-certified since 2008.
Välja site GMP-certified since 2026.

Good Distribution Practice (GDP)

EU standard ensuring compliant sourcing, handling, storage, and transport of pharmaceutical materials.

GDP-certified since 2025.

Download presentation

Discover our capabilities in one deck. Download the TBD Pharmatech Overview Presentation below.


    TBD Pharmatech over the years

    From Foundation to the Forefront

    2026

    Välja GMP Certificate Issuance

    Read more

    2025

    Completion of Välja Facility Construction & Operational Launch

    Read more

    2024

    New Välja Facility Construction

    Read more

    2023

    Manufacturing Expansion in Tartu

    Read more

    2022

    Team Growth & Rebrand

    Read more

    2020

    Awards & New Facilities Planning

    Read more

    2019

    Global Reach & Strategic Investment

    Read more

    2018

    Team Expansion & ISO 9001

    Read more

    2013

    Broad Partnerships & New Capabilities

    Read more

    2012

    Transition to CDMO

    Read more

    2010

    Niche Expertise & New Initiatives

    Read more

    2008

    EU GMP Certification

    Read more

    2007

    Laboratory Expansion & Regional Collaboration

    Read more

    2006

    Founding

    Read more
    Tiefenbacher
    Galmed Pharmaceuticals
    Cfm
    Double Bound Pharmaceutical
    Alfasan International